Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
08/2012
08/22/2012CN102040667B Method for biologically removing protein from sea cucumber polysaccharide
08/22/2012CN102010460B Tea seed polypeptide and preparation method thereof
08/22/2012CN102008472B Compound pioglitazone hydrochloride/metformin hydrochloride bilayer osmotic pump controlled release preparation and preparation method thereof
08/22/2012CN102000064B Medicinal application of flavanonol lignan in preparation glycosidase inhibitors
08/22/2012CN102000062B Application of E ring bromine substituted silybin to preparing glycosidase inhibitors
08/22/2012CN102000060B Application of E ring iodine substituted silybin to preparing glycosidase inhibitors
08/22/2012CN102000059B Medicinal application of querecetin dipolymer flavonoids to preparation of glycosidase enzyme inhibitors
08/22/2012CN101967113B 3-alloc amido-3-(3- nitryl-4-fluorophenyl) propionic acid and preparation method thereof
08/22/2012CN101962349B 3-Boc amidocyanogen-3-(3-nitryl-4-fluorophenyl) monoprop and preparation method thereof
08/22/2012CN101870694B 8,8-disubstituted-13,13a-dihyrdroberberine derivative as well as pharmaceutical composition and application thereof
08/22/2012CN101829290B Medicament for treating diabetic peripheral neuropathy and preparation method thereof
08/22/2012CN101780070B Pharmaceutical composition for treating diabetic nephropathy and preparation method thereof
08/22/2012CN101780069B Drug composite for preventing diabetic nephropathy and preparation method thereof
08/22/2012CN101766812B Liquid drug combination containing exenatide or analogues thereof
08/22/2012CN101711582B Composition containing American ginseng extract and probiotics and application thereof
08/22/2012CN101697803B Grain coix seed porridge medicated food and preparation method thereof
08/22/2012CN101658598B Method for extracting and enriching alisma total triterpenic ketone alcohol components from alisma
08/22/2012CN101649004B Marine oligosaccharide compound with type II diabetes resisting activity and preparation method thereof
08/22/2012CN101637145B Biotransformation high GTF activity milk and manufacturing method thereof
08/22/2012CN101618044B Capsule containing ginseng saponin, radix notoginseng saponin and amino acids and preparation method thereof
08/22/2012CN101559157B Method for fractional extraction of asparagus saponin and asparagus amylose using asparagus slag
08/22/2012CN101480405B Oryzanol composition and preparation method thereof
08/22/2012CN101375978B Medicinal composition for lowering blood fat
08/22/2012CN101346346B Amine compound and use thereof for medical purposes
08/21/2012US8247448 Butenoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and use for the treatment of dyslipidaemia, atherosclerosis and diabetes
08/21/2012US8247432 Tripeptidyl peptidase inhibitors
08/21/2012US8247408 Pyridopyrimidinone inhibitors of PI3Kα for the treatment of cancer
08/21/2012US8247403 Benzoxazepine derivatives and use thereof
08/21/2012US8246540 System for determining insulin dose using carbohydrate to insulin ratio and insulin sensitivity factor
08/21/2012CA2604253C Dietary supplement, and methods of use
08/21/2012CA2514090C Use of glutathione synthesis stimulating compounds in reducing insulin resistance
08/21/2012CA2509086C Substituted arylcyclopropylacetamides as glucokinase activators
08/21/2012CA2497351C Novel aminoindazole derivatives as medicines and pharmaceutical compositions containing same
08/21/2012CA2483848C Antibody against human insulin-like growth factor
08/21/2012CA2473886C Non-steroidal ligands for the glucocorticoid receptor, compositions and uses thereof
08/21/2012CA2408032C Preparation for the prevention and/or treatment of vascular disorders
08/21/2012CA2390129C Slimming composition containing a substance inducing il-6 production
08/21/2012CA2371723C Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidemia and hyperuricemia
08/16/2012WO2012109570A1 Viral vectors with modified transduction profiles and methods of making and using the same
08/16/2012WO2012108622A1 Composition for preventing or treating obesity, dyslipidemia, fatty liver or diabetes containing indole-3-carbinol derivative as active ingredient
08/16/2012WO2012108478A1 Monocyclic compound
08/16/2012WO2012108476A1 Method for producing radioactively labeled polypeptide
08/16/2012WO2012108131A1 Cholesterol level-lowering agent, triglyceride level-lowering agent, blood sugar level-lowering agent, cholesterol adsorbent, adsorbent, triglyceride adsorbent, health food, health supplement, food with nutrient function claims, food for specified health use, quasi-pharmaceutical product, and pharmaceutical product
08/16/2012WO2012107476A1 Pharmaceutical composition, methods for treating and uses thereof
08/16/2012WO2012107073A1 Ubiad1 for cellular coenzyme q10 synthesis and cardiovascular oxidative protection
08/16/2012WO2012106761A1 Sugar extracts
08/16/2012WO2012085266A3 Composition comprising cinnamon extract
08/16/2012WO2012079721A8 Terpenoid spiro ketal compounds with lxr agonists activity, their use and formulations with them
08/16/2012WO2012075081A3 High-strength testosterone undecanoate compositions
08/16/2012WO2012068456A3 Compositions and methods for treating obesity
08/16/2012WO2012054920A3 Antigen-specific, tolerance-inducing microparticles and uses thereof
08/16/2012WO2012037380A3 Formulations of guanylate cyclase c agonists and methods of use
08/16/2012WO2011105099A8 Compound containing a novel 4-alkoxypyrimidine formation and medicine containing same
08/16/2012US20120210465 Production of Polyunsaturated Fatty Acids, Novel Biosynthesis Genes, And Novel Plant Expression Constructs
08/16/2012US20120210451 Islet cell sheet, process for production thereof, and use thereof
08/16/2012US20120209050 Novel pyridopyrazine derivatives, process of manufacturing and uses thereof
08/16/2012US20120208876 Amino acid derivatives for the treatment of neuropathic pain
08/16/2012US20120208864 Compounds and methods for modulating expression of gcgr
08/16/2012US20120208863 Modulation of glut4 gene promoter activity by ahnak
08/16/2012US20120208862 Rip140 regulation of glucose transport
08/16/2012US20120208854 Therapeutic combination
08/16/2012US20120208850 Methods, compounds, and compositions for delivering 1,3-propanedisulfonic acid
08/16/2012US20120208846 Therapeutic Methods For Type I Diabetes
08/16/2012US20120208843 Method of Using GPR35 to Identify Metabolic-Stabilizing Compounds
08/16/2012US20120208841 Modulators of Cystic Fibrosis Transmembrane Conductance Regulator
08/16/2012US20120208836 Compositions and methods for the treatment of obesity and related disorders
08/16/2012US20120208830 Anhydrous Crystalline Forms of N-[1-(2-ethoxyethyl)-5-(N-ethyl-N-methylamino)-7-(4-methylpyridin-2-yl-amino)-1H-pyrazolo[4,3-d]pyrimidine-3-carbonyl]methanesulfonamide
08/16/2012US20120208818 Compounds useful as antagonists of ccr2
08/16/2012US20120208816 Organic compounds
08/16/2012US20120208812 DISUBSTITUTED OCTAHYDROPYRROLO[3,4-c]PYRROLES AS OREXIN RECEPTOR MODULATORS
08/16/2012US20120208810 Novel 1,2,3,4-tetrahydro-pyrimido(1,2-a)pyrimidin-6-one derivatives, preparation thereof, and pharmaceutical use thereof
08/16/2012US20120208805 Triazolium salts as par1 inhibitors, production thereof, and use as medicaments
08/16/2012US20120208804 Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1 based on the 1,3 -oxazinan- 2 -one structure
08/16/2012US20120208797 Pyrimidone derivatives
08/16/2012US20120208793 Thieno- and furo-pyrimidine modulators of the histamine h4 receptor
08/16/2012US20120208777 Diosmetin compounds, a process for their preparation and pharmaceutical compositions containing them
08/16/2012US20120208755 Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
08/16/2012US20120208751 Methods for Regulating Neurotransmitter Systems by Inducing Counteradaptations
08/16/2012US20120208750 Use of protein kinase c delta (pkcd) inhibitors to treat diabetes, obesity, and hepatic steatosis
08/16/2012US20120208749 Insulin derivatives
08/16/2012US20120208748 Peptide compositions and methods for treating patients
08/16/2012US20120208747 Novel peptide for augmenting and expression of bdnf and pharmaceutical composition for prevention and treatment of neurodegenerative diseases including alzheimer's disease or parkinson's disease, comprising the same
08/16/2012US20120207850 Methods for Increasing the Kinetic Activity of Alcohol, Water and Other Liquids, so as to Render the Liquids More Useful in Enhancing the Alternative Cellular Energy Pathway in the Prevention and Therapy of Diseases
08/16/2012US20120207846 Selenium Nanoparticles with Improvded Biological Effects
08/16/2012US20120207845 Pharmaceutical composition of nanoparticles
08/16/2012US20120207825 Pharmaceutical compositions for reducing alcohol-induced dose dumping
08/16/2012US20120207800 Compositions
08/16/2012US20120207773 Materials and methods for the development of an antigen-specific immune non-responsiveness state
08/16/2012US20120207768 Cd38 and obesity
08/16/2012US20120207745 Composition to Induce Specific Immune Tolerance
08/16/2012US20120207741 Enzymes For Pharmaceutical Use
08/16/2012US20120207725 Mesenchymal stem cell incorporating a nucleotide sequence coding tgfb, and uses thereof
08/16/2012US20120207721 Sorcs1 for the treatment of obesity
08/16/2012US20120207719 Pancreatic islet-like cells
08/16/2012US20120207713 Probiotic bifidobacterium strains
08/16/2012US20120207680 Methods of Identifying Candidate Compounds of the Human G Protein-Coupled Receptor, GPR50, as Modulators of Body Mass or Adiposity
08/16/2012US20120207671 Combination treatment with vegf-c antagonists
08/16/2012DE102011011402A1 Preparing a composition, useful to prepare functional food, comprises mixing milled tartary buckwheat with a protein solution, leaving the mixture for a specified range of seconds and cooling the mixture at specified range of temperature
08/16/2012CA2827029A1 Peptide compositions and methods for treating patients
08/16/2012CA2826273A1 Viral vectors with modified transduction profiles and methods of making and using the same
1 ... 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 ... 1298